Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function

Standard

Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function. / Paparoupa, Maria; Pietrzak, Sebastian; Gillissen, Adrian.

In: Case Rep Med, Vol. 2014, 22.07.2014, p. 562929.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{51b5479b57bc4adab513144ab1bd76c6,
title = "Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function",
abstract = "We report a rare case of severe acute rhabdomyolysis in association with coadministration of levofloxacin and simvastatin in a patient with normal renal function. A 70-year-old Caucasian male was treated due to community acquired pneumonia with levofloxacin in a dosage of 500 mg once and then twice a day. On the 8th day of hospitalization the patient presented with acute severe rhabdomyolysis requiring an intensive care support. After discontinuation of levofloxacin and concomitant medication with simvastatin 80 mg/day, clinical and laboratory effects were totally reversible. Up to now, levofloxacin has been reported to induce rhabdomyolysis mainly in patients with impaired renal function, as the medication has a predominant renal elimination. In our case renal function remained normal during the severe clinical course. According to a recent case report rhabdomyolysis was observed due to interaction of simvastatin and ciprofloxacin. To our best knowledge this is the first case of interaction between simvastatin and levofloxacin to be reported. This case emphasizes the need of close monitoring of creatine kinase in patients under more than one potentially myotoxic medication especially when patients develop muscle weakness.",
keywords = "Journal Article",
author = "Maria Paparoupa and Sebastian Pietrzak and Adrian Gillissen",
year = "2014",
month = jul,
day = "22",
doi = "10.1155/2014/562929",
language = "English",
volume = "2014",
pages = "562929",
journal = "CASE REP MED",
issn = "1687-9627",
publisher = "Hindawi Limited",

}

RIS

TY - JOUR

T1 - Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function

AU - Paparoupa, Maria

AU - Pietrzak, Sebastian

AU - Gillissen, Adrian

PY - 2014/7/22

Y1 - 2014/7/22

N2 - We report a rare case of severe acute rhabdomyolysis in association with coadministration of levofloxacin and simvastatin in a patient with normal renal function. A 70-year-old Caucasian male was treated due to community acquired pneumonia with levofloxacin in a dosage of 500 mg once and then twice a day. On the 8th day of hospitalization the patient presented with acute severe rhabdomyolysis requiring an intensive care support. After discontinuation of levofloxacin and concomitant medication with simvastatin 80 mg/day, clinical and laboratory effects were totally reversible. Up to now, levofloxacin has been reported to induce rhabdomyolysis mainly in patients with impaired renal function, as the medication has a predominant renal elimination. In our case renal function remained normal during the severe clinical course. According to a recent case report rhabdomyolysis was observed due to interaction of simvastatin and ciprofloxacin. To our best knowledge this is the first case of interaction between simvastatin and levofloxacin to be reported. This case emphasizes the need of close monitoring of creatine kinase in patients under more than one potentially myotoxic medication especially when patients develop muscle weakness.

AB - We report a rare case of severe acute rhabdomyolysis in association with coadministration of levofloxacin and simvastatin in a patient with normal renal function. A 70-year-old Caucasian male was treated due to community acquired pneumonia with levofloxacin in a dosage of 500 mg once and then twice a day. On the 8th day of hospitalization the patient presented with acute severe rhabdomyolysis requiring an intensive care support. After discontinuation of levofloxacin and concomitant medication with simvastatin 80 mg/day, clinical and laboratory effects were totally reversible. Up to now, levofloxacin has been reported to induce rhabdomyolysis mainly in patients with impaired renal function, as the medication has a predominant renal elimination. In our case renal function remained normal during the severe clinical course. According to a recent case report rhabdomyolysis was observed due to interaction of simvastatin and ciprofloxacin. To our best knowledge this is the first case of interaction between simvastatin and levofloxacin to be reported. This case emphasizes the need of close monitoring of creatine kinase in patients under more than one potentially myotoxic medication especially when patients develop muscle weakness.

KW - Journal Article

U2 - 10.1155/2014/562929

DO - 10.1155/2014/562929

M3 - SCORING: Journal article

C2 - 25140181

VL - 2014

SP - 562929

JO - CASE REP MED

JF - CASE REP MED

SN - 1687-9627

ER -